Cytoreductive surgery in the primary management of advanced epithelial ovarian carcinoma: A topic for debate

被引:9
|
作者
Girling, JC
Soutter, WP
机构
[1] Inst. of Obstetrics and Gynaecology, Hammersmith Hospital, London W12 0HS, Du Cane Road
关键词
advanced ovarian carcinoma; cytoreductive surgery;
D O I
10.1046/j.1525-1438.1996.06020081.x
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
While there is no doubt that surgical resection of early stage ovarian cancer can be curative, the effect of cytoreductive surgery on the prognosis in advanced disease is less certain. A recent EORTC study does suggest that intervention debulking surgery might improve survival and this requires urgent confirmation. Extensive cytoreductive surgery, removing bowel, parts of the urinary tract or lymph nodes, may have little impact on the survival of women with advanced disease and can result in substantial morbidity. Discretion and experience are required in determining the appropriate radicality of tumor resection to avoid predictable impairment of quality of life.
引用
收藏
页码:81 / 84
页数:4
相关论文
共 50 条
  • [1] Primary cytoreductive surgery with rectosigmoid colon resection for patients with advanced epithelial ovarian carcinoma
    Scarabelli, G
    Gallo, A
    Franceschi, S
    Campagnutta, E
    De Piero, G
    Giorda, G
    Visentin, MC
    Carbone, A
    CANCER, 2000, 88 (02) : 389 - 397
  • [2] Splenectomy during primary and secondary cytoreductive surgery for epithelial ovarian carcinoma
    Scarabelli, C
    Gallo, A
    Campagnutta, E
    Carbone, A
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 1998, 8 (03) : 215 - 221
  • [3] Cytoreductive surgery for advanced ovarian cancer
    Poelcher, Martin
    Zivanovic, Oliver
    Chi, Dennis S.
    WOMENS HEALTH, 2014, 10 (02) : 179 - 190
  • [4] Cytoreductive surgery combined with organ resection for advanced ovarian carcinoma
    Y. Todo
    N. Sakuragi
    M. Oikawa
    H. Negishi
    R. Yamamoto
    K. Yoshiaki
    N. Tsumura
    I. Kawaguchi
    S. Fujimoto
    International Journal of Clinical Oncology, 2003, 8 (2) : 90 - 96
  • [5] Impact of interval from primary cytoreductive surgery to initiation of adjuvant chemotherapy in advanced epithelial ovarian cancer
    Lee, Yoo-Young
    Lee, Jeong-Won
    Lu, Lin
    Xu, Wei
    Kollara, Alexandra
    Brown, Theodore
    Heo, Eun-Jin
    May, Taymaa
    INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS, 2018, 143 (03) : 325 - 332
  • [6] Feasibility and outcome of primary laparoscopic cytoreductive surgery for advanced epithelial ovarian cancer: a comparison to laparotomic surgery in retrospective cohorts
    Liang, Huamao
    Guo, Hongyan
    Zhang, Chunyu
    Zhu, Fuli
    Wu, Yu
    Zhang, Kun
    Li, Hua
    Han, Jinsong
    ONCOTARGET, 2017, 8 (68) : 113239 - 113247
  • [7] Primary debulking surgery and neoadjuvant chemotherapy in the treatment of advanced epithelial ovarian carcinoma
    Seward, Shelly M.
    Winer, Ira
    CANCER AND METASTASIS REVIEWS, 2015, 34 (01) : 5 - 10
  • [8] Cytoreductive surgery and HIPEC after neoadjuvant chemotherapy for advanced epithelial ovarian cancer
    Marco Lotti
    Luisa Maria Busci
    Luca Campanati
    Fausto Catena
    Federico Coccolini
    Naoual Bakrin
    Pierandrea De Iaco
    Giorgio Ercolani
    Giuseppe Grosso
    Michele Pisano
    Elia Poiasina
    Diego Rossetti
    Martina Rossi
    Claudio Zamagni
    Paolo Bertoli
    Antonio Daniele Pinna
    Luigi Frigerio
    Luca Ansaloni
    World Journal of Obstetrics and Gynecology, 2013, (04) : 167 - 175
  • [9] Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for the treatment of advanced epithelial and recurrent ovarian carcinoma: a single center experience
    Pavlov, Maja J.
    Ceranic, Miljan S.
    Latincic, Stojan M.
    Sabljak, Predrag V.
    Kecmanovic, Dragutin M.
    Sugarbaker, Paul H.
    INTERNATIONAL JOURNAL OF HYPERTHERMIA, 2018, 34 (05) : 564 - 569
  • [10] The role of secondary cytoreductive surgery in the treatment of patients with recurrent epithelial ovarian carcinoma
    Eisenkop, SM
    Friedman, RL
    Spirtos, NM
    CANCER, 2000, 88 (01) : 144 - 153